Firms
Theme

ACH

Accendra Health, Inc. · NYSE

$0.2173USDCS band Caution

↑ $0.01 (3.08%)

Last close · Oct 23, 4:00 PM ET

Sign up free to see this.

Mkt Cap
$36.1M
Volume
18.3K
52W High
$5.60
52W Low
$0.1910
PE Ratio
—
Avg Vol
2M
As of 10/23/26
Div Yield
—
Beta
0.92
As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about ACH?

Latest news

News ›

Zacks Investment Research

New Strong Sell Stocks for October 9th

Zacks has added three stocks to its Strong Sell list: Accendra Health (ACH), Ardelyx (ARDX), and Draganfly (DPRO). All three companies have experienced significant downward revisions to their earnings estimates over the past 60 days, with ACH seeing a 109.4% downward revision, ARDX a 25% revision, and DPRO a 59.6% revision.

Zacks Investment Research

New Strong Sell Stocks for October 6th

Three companies have been added to the Zacks Rank #5 (Strong Sell) list today due to downward revisions in earnings estimates. AB Volvo faces a 2.3% downward earnings revision, Accendra Health has experienced a significant 109.4% downward revision, and Cameco Corporation saw a 12.2% downward revision over the last 60 days.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $ACH · 0 threads

Sign in to post on $ACH

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev